Serum Biomarkers for Portal Hypertension in Cirrhosis (Pan-CHESS1802)

Status Recruiting

Clinical Trial Summary

This is a prospective, multi-center diagnostic trial conducted at 6 liver centers in China designed to study the correlation between serum biomarkers associated with endothelial dysfunction and immune inflammation and hepatic venous pressure gradient in cirrhosis.

Clinical Trial Description

Hepatic venous pressure gradient (HVPG) is the gold standard for assessing portal pressure, of which the measurement is invasive and therefore not suitable for routine clinical practice. The detection of serum biomarkers is potential for noninvasive diagnosis of portal hypertension in cirrhosis. However, many are still in the exploratory phases of testing and are not yet ready to enter clinical practice. This study prospectively enrolled participants in 6 liver centers (Beijing YouAn Hospital, Shandong Provincial Hospital, Beijing Shijitan Hospital, Beijing Friendship Hospital, Xingtai People's Hospital, and 302 Hospital of PLA) in China designed to study the correlation between serum biomarkers associated with endothelial dysfunction and immune inflammation and HVPG in cirrhosis. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03713606
Study type	Observational
Source	Nanfang Hospital of Southern Medical University
Contact	Xiaolong Qi, M.D.
Phone	+86 18588602600
Email	qixiaolong@vip.163.com
Status	Recruiting
Phase
Start date	September 30, 2018
Completion date	June 1, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02505152` - Percutaneous Transhepatic Intrahepatic Portosystemic Shunt for Treatment of Portal Vein Occlusion With Symptomatic Portal Hypertension After Splenectomy	N/A
Recruiting	`NCT02504034` - Interventional Radiology for the Treatment of Symptomatic Portal Hypertension in Patients With Cavernous Transformation of Portal Vein	N/A
Completed	`NCT02669875` - Serelaxin To Lower Portal Pressure	Phase 2
Recruiting	`NCT04720456` - SHAPE of Portal Hypertension in Children	Phase 2
Completed	`NCT04645550` - Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）	Phase 4
Recruiting	`NCT02305914` - Follow-up Study of Complications of Acute Pancreatitis	N/A
Completed	`NCT01095185` - Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal Bleeding	Phase 3
Terminated	`NCT05282121` - A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)	Phase 2
Completed	`NCT00004641` - A Study to Prevent Complications of High Blood Pressure Caused by Hepatitis in Patients With Cirrhosis	Phase 2
Completed	`NCT03138915` - Radiomics Signature of Hepatic Venous Pressure Gradient (rHVPG) With CT Angiography (CHESS1701)	N/A
Completed	`NCT03175731` - PPIs and Gastroesophageal Varices in Liver Cirrhosis (PPIs: Proton Pump Inhibitors)	Phase 4
Active, not recruiting	`NCT04315571` - Comparing Ascites Relief In Two Standard Treatments: Large Volume Paracentesis Vs. Early Tips Using Viatorr Controlled Expansion Stents	N/A
Completed	`NCT03459378` - Outcome After TIPS
Recruiting	`NCT03470389` - Establishment and Assessment of the HVPG Using Biofluid Mechanics (HVPGBFM)	N/A
Completed	`NCT02462967` - Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis	Phase 2
Active, not recruiting	`NCT01097811` - Comparison Between Erythromycin and Neomycin Treatment of Hepatic Encephalopathy	N/A
Terminated	`NCT06082843` - A Study to Test Whether Avenciguat Helps People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) Who Had Bleeding in the Esophagus or Fluid Accumulation in the Belly	Phase 2
Recruiting	`NCT03315767` - Spleen-ARFI-assisted-Portal-Hypertension-Evaluation-Study (SAPHES)	N/A
Terminated	`NCT05161481` - A Study to Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Live	Phase 2
Completed	`NCT03766880` - MR-based Models for Clinically Significant Portal Hypertension in Cirrhosis (CHESS1802)	N/A